Core Viewpoint - The acquisition of a controlling stake in Upwind New Materials by Zhiyuan Robotics marks a significant move towards establishing a humanoid robotics company on the STAR Market, potentially positioning it as the first humanoid robot stock in A-shares [3][4][15]. Group 1: Acquisition Details - On July 9, Upwind New Materials announced that Zhiyuan Robotics, through its controlled entity Zhiyuan Hengyue, will acquire at least 63.62% of its shares for no less than 1.996 billion yuan [1][2]. - Following the transaction, the controlling shareholder and actual controller of Upwind New Materials will change to Zhiyuan Hengyue and Deng Taihua [2]. - The market reacted positively, with Upwind New Materials hitting the daily limit up on the announcement day [6]. Group 2: Future Listing Potential - If the acquisition is successful, Upwind New Materials could become the first humanoid robotics company listed on the STAR Market [3]. - There is speculation about whether Upwind New Materials will serve as a future listing platform for Zhiyuan Robotics, enhancing its position in the A-share market [4][15]. - Zhiyuan Robotics has a valuation of 15 billion yuan, significantly higher than Upwind New Materials' 3.1 billion yuan market cap, creating substantial market expectations [13][14]. Group 3: Paths to Listing - Three potential paths for Zhiyuan Robotics to achieve a public listing through Upwind New Materials are identified: reverse merger, restructuring after a 36-month waiting period, and gradual asset injection [11][28]. - The reverse merger path faces challenges, including stringent financial requirements and a lack of precedents in the STAR Market [19][21]. - The restructuring option would require a waiting period of 36 months, raising concerns about the future market conditions for the robotics industry [23][27]. - Gradual asset injection could avoid the classification of a reverse merger, but it also presents challenges regarding the timing and industry synergy [28][38]. Group 4: Financial Implications - The acquisition involves a total consideration of approximately 1.1 billion yuan, funded through Zhiyuan Robotics' own capital and acquisition loans [50]. - Although leveraging is involved, the transaction is expected to enhance Zhiyuan Robotics' financing capabilities post-acquisition [52]. - The potential for stock pledge financing could arise as Upwind New Materials' value increases, providing low-cost financing options for Zhiyuan Robotics [53]. Group 5: Market Context - The current stringent IPO review process in the A-share market may lead early-stage tech companies to consider similar acquisition strategies as a viable path to public listing [54]. - Recent cases of innovative acquisitions in the market suggest a growing trend towards such strategies, although the success of these operations remains uncertain [55].

智元机器人的资本首秀来了。 7月9日，上纬新材（688585.SH）宣布上海智元新创技术有限公司（下称"智元机器人"）控制的主体上海智元恒岳科技合伙企业（有限合伙）（下 称"智元恒岳"）、及关联方上海致远新创科技设备合伙企业（有限合伙）（下称"致远新创"）将至少收购其63.62%股份，交易作价不低于19.96亿 元。 交易完成后，上纬新材的控股股东、实控人将双双变更为智元恒岳、邓泰华。 若该交易达成，上纬新材将成为科创板首家人形机器人企业旗下公司。 市场的期待显然不仅于此，更受关注的，莫过于改朝换代的上纬新材能否成为智元机器人未来的上市平台，进而跻身A股市场"人形机器人第一 股"。 虽然智元机器人强调最近12个月内并未有向上纬新材注入资产的计划。 但市场依旧反应激烈，当日上纬新材开盘一字涨停。 从实操来看，智元机器人若想以上纬新材为主体上市确实不是易事。 目前智元机器人的估值是上纬新材的数倍，短期内注入资产大概率构成借壳上市，这在科创板中未有先例； 但这并不意味着智元机器人会就此罢手。 在现行规则下，其仍然可通过36个月后重组或将资产"分步走"等方式来规避"借壳上市"认定审查，但届时机器人行业是否依旧保持高景 ...

将投中网设为"星标⭐"，第一时间收获最新推送 最近，不少"大佬"都通过买"壳"来获取财务收益。 作者丨 王满华 来源丨 投中网 又一互联网大佬盯上了上市公司控制权。 近日， A 股上市公司易明医药发布公告称，北京福好拟斥资 6.62 亿元收购实控人高帆持有的 23% 股份，交易完成后，公 司控股股东将由高帆变更为北京福好。股权穿透显示，北京福好的实际控制人正是 58 同城创始人姚劲波。 这是姚劲波在A股的公开投资首秀，市场也给予了积极反馈，公告发布后，易明医药连续收获7个涨停板。截至6月13日收盘， 易明医药股价为22.45元/股，市值42.81亿元，6月以来累计涨幅高达84.32%。 根据公告，此次交易的转让价格为 15.1 元 / 股。也就是说，收购尚未完成，姚劲波就已提前收获了浮盈。 近两年，并购热度居高不下，有接近 58 同城的朋友告诉我，在政策层面的不断利好下，不少"大佬"都通过买"壳"来获取财 务收益，姚劲波同样表现出浓厚兴趣。由此来看，此番拿下易明医药的实控权，或许只是姚劲波在二级市场"落子"的开端。 而盯上上市公司控制权的并非仅有产业大佬，不止一位投资人表示，现在"就连政府也开始热衷'买壳'了 ...